Overview
Recurrent Neisseria infections due to factor D deficiency (also known as complement factor D deficiency or properdin factor D deficiency) is an extremely rare primary immunodeficiency disorder caused by a deficiency of complement factor D, a key serine protease in the alternative pathway of the complement system. Factor D is essential for cleaving factor B when it is bound to C3b, thereby initiating and amplifying the alternative complement pathway. Without functional factor D, the alternative pathway cannot be properly activated, leaving affected individuals highly susceptible to invasive infections by encapsulated bacteria, particularly Neisseria meningitidis (meningococcus) and Neisseria gonorrhoeae. The disease primarily affects the immune system, with clinical manifestations including recurrent and severe meningococcal meningitis, meningococcal septicemia (meningococcemia), and other invasive Neisseria infections. These infections can be life-threatening and may present in childhood or early adulthood. Affected individuals may experience multiple episodes of meningococcal disease, which is unusual in the general population. Other encapsulated organisms such as Streptococcus pneumoniae may also cause serious infections in these patients. Management focuses on prevention and early treatment of infections. Vaccination against Neisseria meningitidis (meningococcal vaccine covering multiple serogroups) is strongly recommended, although vaccine efficacy may be reduced due to the underlying complement deficiency. Prophylactic antibiotics may be considered in some cases. Prompt recognition and aggressive antibiotic treatment of acute infections is critical. Genetic counseling is recommended for affected families. There is currently no curative therapy to restore complement factor D function, and lifelong vigilance against invasive bacterial infections is necessary.
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
2 eventsCoartem: FDA approved
Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum
Salagen: FDA approved
Treatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Recurrent Neisseria infections due to factor D deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Recurrent Neisseria infections due to factor D deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Recurrent Neisseria infections due to factor D deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesCoartem
Novartis Pharmaceuticals
Coartem Patient Support (Novartis Patient Assistance)
Salagen
MGI Pharma, Inc.
Salagen — Contact MGI Pharma, Inc.
Travel Grants
No travel grants are currently matched to Recurrent Neisseria infections due to factor D deficiency.
Community
No community posts yet. Be the first to share your experience with Recurrent Neisseria infections due to factor D deficiency.
Start the conversation →Latest news about Recurrent Neisseria infections due to factor D deficiency
No recent news articles for Recurrent Neisseria infections due to factor D deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Recurrent Neisseria infections due to factor D deficiency
What is Recurrent Neisseria infections due to factor D deficiency?
Recurrent Neisseria infections due to factor D deficiency (also known as complement factor D deficiency or properdin factor D deficiency) is an extremely rare primary immunodeficiency disorder caused by a deficiency of complement factor D, a key serine protease in the alternative pathway of the complement system. Factor D is essential for cleaving factor B when it is bound to C3b, thereby initiating and amplifying the alternative complement pathway. Without functional factor D, the alternative pathway cannot be properly activated, leaving affected individuals highly susceptible to invasive inf
How is Recurrent Neisseria infections due to factor D deficiency inherited?
Recurrent Neisseria infections due to factor D deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
What treatment and support options exist for Recurrent Neisseria infections due to factor D deficiency?
2 patient support programs are currently tracked on UniteRare for Recurrent Neisseria infections due to factor D deficiency. See the treatments and support programs sections for copay assistance, eligibility, and contact details.